Important from YMB CYDY SUING 13D POINTS: 1) Cydy is

New Post Public Reply Private Reply Replies (0) Message Board
Cycl2R
1,425
Important from YMB

CYDY SUING 13D POINTS:

1) Cydy is NOT suing for monetary damages! Too many people assume when you sue someone it's for money.

Chancery court is for deciding aspects of equity. Not seeking reparations for damages. Case was filed in Delaware chancery court. (Not every state even has a chancery court because of its specific purpose). In fact, there are no juries in Chancery court. It's all adjudicated by judges.

Chancery court is for suing to obtain some form of non-monetary award.

We actually know from the court filing what this is. Cytodyn is seeking an injunction against 13D group from making statements about their goals, aims, etc because they have misled investors that caused a drop in SP. In essence the lawsuit is to silence them under order (gag order if you will)

2) Proof of claims: Cytodyn claims are a binary event and the 13D group doesn't have any real wiggle room.

Did 13D file documents that didn't expose former BOD, employees, and relationship with Bruce P. Which led to investors being misled as to 13D intentions? We know the answer to this is yes and there are fifty such (and I am certain Sidley has verified) infractions.

Since 13D can't argue the filing wasn't missing the info, they could argue the information itself is wrong. Did Dr. P work previously with Cytodyn and a proposed buyout that went south? Did he try to patent material not his? Did Caracciolo and Pestell previously work for Cytodyn?

We know these facts to be true as well.

So 13D can't say the facts they left out are incorrect and they can't say they didn't leave them out.

The chancery court is giving them five days for an answer but without a rabbit from a hat, this case is going to be decided rather quickly.

3) a long drawn out court case? No, it appears there has been a request to expedite. For the reasons listed above this seems most likely. Doubtful this case is going to cost millions as people suggest or fear.

3) NP has made a tactical error by opening himself up to deposition? This is just FUD. The suit is actually very target specific. It's designed to shut up the 13D group. Even if it did get dragged out, saying NP deceived investors is not an excuse for 13D deceiving investors. If that's the defense tactic they are on their way to a major loss. But it's almost certainly not going that direction. Again this about forcing 13D to no longer make comments or seek the proxy vote.

4) the death knell for 13D. With 13D disqualified from the proxy vote and if Cytodyn wins this case, the 13D ordered by chancery court to cease and desist, that's the end of 13D.

5) Why spend the money on this? Some posters are saying this is just a greedy means for current BOD to keep their jobs. Probably but who wouldn't try to keep their job especially if they have done the hard work of a decade and someone else is trying to steal it at the gates to success?

But as some posters have hypothesized, this may actually be a means to discuss a merger with big pharma.

Don't let the bashers deceive you. They keep saying no merger can happen with a lawsuit hanging over Cytodyn head. Correct, so ask yourself why Cytodyn filed this suit?

My theory:. No big pharma will discuss a merger with a proxy battle ongoing. The suit as mentioned above is to completely crush and eradicate the 13D proxy battle. Once that is out of the way, any merger discussion can be resumed.

If that is the purpose of the lawsuit, to pave the way for a merger, then it appears to be well justified in my opinion.
Less
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 126

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 139

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 78

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 75

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 88

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Guangdong-US Trade: LED Screens, Beef & Trust Make Waves

Updated Category News Views 81

Guangdong's Economic Ballet with the U.S. Grab a cup of coffee, and let's unravel how Guangdong and the U.S. are tangoing their way through trade like nobody's business! Guangdong, the heavyweight champ for U.S.-China trade transactions, notched up a cool 685.27 billion yuan ($102 billion) in the first eight months of 2026. That's a healthy jump of 6.9% year on year, mind...

Continue Reading
Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 44

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 107

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Exploring Why Dead Outlets Stay Dead: Expert Insights

Updated Category News Views 86

The Mystery of Non-Responsive Outlets Ever found an electrical outlet refusing to cooperate when you need it most? Well, I know the frustration all too well. You'd think if the breaker ain't blown, the outlet should work like a charm. But dive into the guts of the story, and you find a series of surprises waiting to trip us up. Common Culprits: Tripped GFCIs and Loose...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 147

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Nulogy and Kinaxis Team Up to Transform Supply Chain Dynamics

Updated Category News Views 125

Strategic Alliance Between Nulogy and Kinaxis Nulogy and Kinaxis have formed a significant partnership aimed at improving synchronization within manufacturing supply chain networks. Together, they plan to deliver innovative solutions that will streamline operations for the fast-moving consumer goods (FMCG) and life sciences sectors. Enhancing Collaboration in Supply Chain...

Continue Reading
EssentiallySports Welcomes Natasha Howard as New Correspondent

Updated Category News Views 317

EssentiallySports Welcomes Natasha Howard as New Correspondent Indiana Fever Star to Serve as Athlete Correspondent, Providing Exclusive Behind-the-Scenes Access EssentiallySports, a leading sports media publisher, has forged an exciting partnership with three-time WNBA champion Natasha Howard, known for her outstanding performances with the Indiana Fever. Howard’s new...

Continue Reading
Sinch Unveils Innovative RCS Business Service for Telcos

Updated Category News Views 194

Sinch's Cutting-Edge RCS Business Enablement Service Sinch is leading the way in transforming communication for businesses with its latest offering: the RCS Business Enablement service. This service aims to streamline RCS operations, enhancing monetization and simplifying financial management for telecom operators. As the mobile messaging landscape evolves, enterprises...

Continue Reading
Viking Therapeutics Reveals Promising Results for VK2735 in Obesity

Updated Category News Views 201

Viking Therapeutics Announces Breakthrough Findings in Obesity Treatment Viking Therapeutics, Inc. recently shared impressive news regarding the results from their Phase 2 clinical trial of VK2735, a dual agonist designed to tackle obesity. Ensuring patients can combat weight-related issues is a growing concern, and VK2735’s performance offers a beacon of hope....

Continue Reading
Elev8 Corporate Finance Announces Innovative Flat-Fee Model

Updated Category News Views 242

Elev8 Revolutionizes Bridge Financing for Businesses Elev8 Corporate Finance, a prominent private credit advisor, has unveiled an innovative compensation model aimed at empowering lower-middle-market businesses. This new flat-fee plus exit strategy unlike traditional broker commissions, promises a quicker and more cost-effective solution for securing bridge capital....

Continue Reading